Brian Goldstein, Bob Licht, Charles Lyon
Eric Marandett, Fred Callori Brenda Jarrell
Choate recently obtained a preliminary injunction for Momenta Pharmaceuticals in a patent infringement action to preserve exclusivity in sales of the only generic form of enoxaparin, which had more than $1 billion in sales in its first 12 months. Choate immediately sued and moved for a TRO and Preliminary injunction based on infringement of two patents covering methods used in the process of making the product, after another party announced in September, 2011 that it had obtained FDA approval to market a second generic enoxaparin. Choate successfully obtained the TRO and then a preliminary injunction after several rounds of briefing and hearings, also surviving a motion to dismiss, thereby successfully keeping the rival product entirely off the market until trial.
Choate represented privately held oncology-focused pharmaceutical company Tesaro, Inc. in its acquisition of an oncology supportive care product from OPKO Health, Inc., a publicly traded healthcare company involved in the discovery, development and commercialization of pharmaceutical products.
Choate counsels multiple companies focused on engineering microbial cells to produce chemical compounds of interest, and the firm has secured for such companies the issued patents to engineered strains.
"the ‘fantastic firm’ has legendary prowess in life sciences and meets the needs of many of the country’s most technically demanding patent holders"
IAM Patent 1000
Nationally Recognized Experts in Life Sciences
Represent leading life sciences companies and institutions in all aspects of their business, including IP protection, strategies, collaborations and licenses, technology transfer, financings, M&A transactions and general advice and counsel.
Representation of emerging and public companies. Expertise in public and private financing representing companies and investors. Preeminent M&A and cross-border transactional practice. Nationally ranked among the leading firms for Life Sciences, M&A, Private Equity Buyouts and Venture Capital and Emerging Companies by The Legal 500 guide to preeminent law firms in US.
Full Range of IP Services
Full range of services, including strategic IP counseling; patent prosecution; trademark prosecution; copyright protection; trade secrets and unfair competition counseling; and IP due diligence for investors and acquirers. Decades of litigation experience representing life sciences companies in IP disputes. One of first major Boston firms to establish patent group. Ranked as patent strategy and management team of the year by LMG Life Sciences. Recognized among the world’s leading patent practitioners for Prosecution and Transactions in the IAM Patent 1000. Ranked as a top Tier 1, “highly recommended” firm for Intellectual Property in Massachusetts, as well as a top firm nationally for Bio Life Sciences, Patent Prosecution and Patent Contentious, by Managing Intellectual Property.
World-Class Transactional & Licensing Capability
Among most experienced and knowledgeable technology transaction, strategic collaboration and licensing lawyers in US, representing pharmaceutical and biotechnology companies in all types of transactions, including strategic alliances, collaborations, joint ventures and license arrangements.
Represent life sciences companies and institutions across United States and many foreign countries. Preeminent US – Canada cross-border practice.